A Double-Blind Randomized Placebo Controlled Trial of Topical Intranasal Corticosteroids in 4- To11-Year-Old Children with Persistent Bilateral Otitis Media with Effusion in Primary Care

Preliminary

1. Appropriate contact details for further information?
Yes

2. Authors identified?
Yes

3. Statement regarding conflict of interest?
Yes

4. Statement on whether report externally reviewed?
Yes

5. Short summary in non-technical language?
Partly


Why?

6. Reference to the policy question that is addressed?
Yes

7. Reference to the research question that is addressed?
Yes

8. Scope of the assessment specified?
Yes

9. Description of the assessed health technology?
Yes


How?


Context?

12. Information on context (may or may not apply to each HTA).


(Medico-) legal implications considered?
Economic analysis provided?
Ethical implications considered?
Social implications considered?
Other perspectives (stakeholders, patients, consumers) considered?
 

What then?

13. Findings of the assessment discussed?
Yes

14. Conclusions from assessment clearly stated
Yes

15. Suggestions for further action?
Yes


Completed by:
Maria Oosterwijk, maria@soton.ac.uk

INAHTA Brief issue: 2009/175

Agency: NETSCC, HTA, NIHR Coordinating Centre for Health Technology Assessment
View contact details


More about this report:
INAHTA Brief in pdf
INAHTA Brief
HTA Database record
Full report/summary

Reference:

Volume 13.37. ISSN 1366-5278


Other publications:
on Otorhinolaryngologic Diseases
from NETSCC, HTA


Glossary, Acronyms & Publications:
HTA Glossary
List of acronyms